Dilute Versus Concentrated Epidural Bupivacaine in Labor
Phase 3
Completed
- Conditions
- PainLabor Complications
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2006-03-03
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 60
- Registration Number
- NCT00197327
- Locations
- 🇮🇱
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
Terminated
- Conditions
- HIV Infections
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-11-28
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 50
- Registration Number
- NCT00197366
- Locations
- 🇮🇱
Kaplan Medical Center, Rehovot, Israel
🇮🇱Meir Hospital Sapir Medical Center, Kfar Saba, Israel
🇮🇱AIDS Center, Hadassah-Hebrew U Medical Organisation, Jerusalem, Israel
Determinants of Warfarin Metabolism
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 600
- Registration Number
- NCT00162474
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Genetic Determinants of Warfarin Anticoagulation Effect
Not Applicable
- Conditions
- Atrial FibrillationVenous ThrombosisPulmonary Embolism
- Interventions
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 500
- Registration Number
- NCT00162435
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Metabolic Capacity of Israeli Populations
Not Applicable
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 1200
- Registration Number
- NCT00162383
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies
Phase 2
Withdrawn
- Conditions
- Multiple MyelomaTumors
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2010-11-10
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 15
- Registration Number
- NCT00162500
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia
Phase 1
Withdrawn
- Conditions
- Chronic Myeloid Leukemia
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2011-04-28
- Lead Sponsor
- Hadassah Medical Organization
- Registration Number
- NCT00162513
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Tocopherol is a Novel Treatment for Cancer Related Mucositis
Phase 2
Withdrawn
- Conditions
- Oral Mucositis
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 30
- Registration Number
- NCT00162526
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
Not Applicable
- Conditions
- HyperkalemiaChronic Renal Failure
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2008-10-29
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 150
- Registration Number
- NCT00162487
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Genetic Determinants of the Response to Salbutamol Among Asthma Patients
Not Applicable
- Conditions
- Asthma
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2008-10-29
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 150
- Registration Number
- NCT00162396
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath